切换至 "中华医学电子期刊资源库"

中华临床实验室管理电子杂志 ›› 2015, Vol. 03 ›› Issue (02) : 93 -96. doi: 10.3877/cma.j.jssn.2095-5820.2015.02.007

综述

神经导向因子4与肿瘤
徐秀平1, 董学君1,()   
  1. 1.312000,绍兴市人民医院 浙江大学绍兴医院
  • 收稿日期:2015-04-22 出版日期:2015-05-28
  • 通信作者: 董学君
  • 基金资助:
    浙江省医药卫生平台计划资助课题(2015DTA018)

Relationship between netrin-4 and tumors

Xiuping Xu1, Xuejun Dong1,()   

  1. 1.Shaoxing People’s Hospital,Shaoxing Hospital of Zhejiang University, Shaoxing 312000, China
  • Received:2015-04-22 Published:2015-05-28
  • Corresponding author: Xuejun Dong
引用本文:

徐秀平, 董学君. 神经导向因子4与肿瘤[J/OL]. 中华临床实验室管理电子杂志, 2015, 03(02): 93-96.

Xiuping Xu, Xuejun Dong. Relationship between netrin-4 and tumors[J/OL]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2015, 03(02): 93-96.

神经导向因子4(netrin-4)是一种分泌蛋白,经其和不同受体结合,参与神经细胞生长、迁移等生理功能。Netrin-4在非神经系统中也可调节细胞生长。体内实验证实,netrin-4具有调节血管生成和促淋巴管形成作用,从而影响肿瘤的发生、发展和转移;体外实验中,netrin-4对肿瘤细胞的增殖、迁移等有不同的作用,可能与netrin-4和不同受体结合有关。肿瘤细胞生长与netrin-4的浓度具有相关性,netrin-4在肿瘤细胞中低表达与甲基化有关。因此,netrin-4及其受体对肿瘤的诊治具有重要意义,有可能成为新的肿瘤治疗靶点。

Neural guidance factor 4 (netrin-4) is a kind of secreted protein; it exerts an influence on physiological functions such as neurocyte growth and migration through binding to its various receptors.Recent studies show that netrin-4 can also regulate cell growth in the non-nervous system. It plays a key role in regulating angiogenesis and promoting lymphogenesis, which influences the occurrence, development and metastasis of tumors; netrin-4 has distinct effects on tumor cell proliferation and migration in vitro experiments, this could be related to binding to different receptors. Moreover, tumor cell growth is associated with the concentration of netrin-4, and low expression of netrin-4 in tumor cells is involved in methylation.Therefore, netrin-4 and its receptors are of great importance in the diagnosis and treatment of tomors, and are likely to be new tumor therapeutic targets in the future.

1
Esseghir S, Kennedy A, Seedhar P, et al. Identification of NTN4,TRA1, and STC2 as prognostic markers in breast cancer in a screen for signal sequence encoding proteins [J]. Clin Cancer Res,2007,13(11):3164-3173.
2
Nacht M, St Martin TB, Byrne A, et al. Netrin-4 regulates angiogenic responses and tumor cell growth [J]. Exp Cell Res, 2009,315(5):784-794.
3
Eveno C, Broqueres-You D, Feron JG, et al. Netrin-4 delays colorectal cancer carcinomatosis by inhibiting tumor angiogenesis [J]. Am J Pathol, 2011,178(4):1861-1869.
4
Eveno C, Contreres JO, Hainaud P, et al. Netrin-4 overexpression suppresses primary and metastatic colorectal tumor progression [J].Oncol Rep, 2013,29(1):73-78.
5
Rajasekharan S, Kennedy TE. The netrin protein family [J]. Genome Biol, 2009,10(9):239.
6
Koch M, Murrell JR, Hunter DD, et al. A novel member of the netrin family, beta-netrin, shares homology with the beta chain of laminin identification, expression, and functional characterization [J]. J Cell Biol, 2000,151(2):221-234.
7
Hayano Y, Sasaki K, Ohmura N, et al. Netrin-4 regulates thalamocortical axon branching in an activity-dependent fashion [J].Proc Natl Acad Sci U S A, 2014,111(42):15226-15231.
8
Schneiders FI, Maertens B, Bose K, et al. Binding of netrin-4 to laminin short arms regulates basement membrane assembly [J]. J Biol Chem, 2007,282(33):23750-23758.
9
Staquicini FI, Dias-Neto E, Li J, et al. Discovery of a functional protein complex of netrin-4, laminin gamma1 chain, and integrin alpha6beta1 in mouse neural stem cells [J]. Proc Natl Acad Sci U S A,2009,106(8):2903-2908.
10
Larrieu-Lahargue F, Welm AL, Thomas KR, et al. Netrin-4 activates endothelial integrin α6β1 [J]. Circ Res, 2011,109(7):770-774.
11
Larrieu-Lahargue F, Welm AL, Thomas KR, et al. Netrin-4 induces lymphangiogenesis in vivo [J]. Blood, 2010,115(26):5418-5426.
12
Dakouane-Giudicelli M, Duboucher C, Fortemps J, et al. Identification and localization of netrin-4 and neogenin in human first trimester and term placenta [J]. Placenta, 2012,33(9):677-681.
13
Wilson BD, Ii M, Park KW, et al. Netrins promote developmental and therapeutic angiogenesis [J]. Science, 2006,313(5787):640-644.
14
Lejmi E, Bouras I, Camelo S, et al. Netrin-4 promotes mural cell adhesion and recruitment to endothelial cells [J]. Vasc Cell, 2014,6(1): 1.
15
Lejmi E, Leconte L, Pédron-Mazoyer S, et al. Netrin-4 inhibits angiogenesis via binding to neogenin and recruitment of Unc5B [J].Proc Natl Acad Sci U S A, 2008,105(34):12491-12496.
16
Lv B, Song C, Wu L, et al. Netrin-4 as a biomarker promotes cell proliferation and invasion in gastric cancer [J]. Oncotarget,2015,6(12):9794-9806.
17
Han Y, Shao Y, Liu T, et al. Therapeutic effects of topical netrin-4 inhibits corneal neovascularization in alkali-burn rats [J]. PloS one,2015,10(4):e0122951.
18
Hoang S, Liauw J, Choi M, et al. Netrin-4 enhances angiogenesis and neurologic outcome after cerebral ischemia [J]. J Cereb Blood Flow Metab, 2009,29(2):385-397.
19
Lambert E, Coissieux MM, Laudet V, et al. Netrin-4 acts as a proangiogenic factor during zebrafish development [J]. J Biol Chem,2012,287(6):3987-3999.
20
Sleeman JP, Thiele W. Tumor metastasis and the lymphatic vasculature[J]. Int J Cancer, 2009,125(12):2747-2756.
21
Hu Y, Ylivinkka I, Chen P, et al. Netrin-4 promotes glioblastoma cell proliferation through integrin β4 signaling [J]. Neoplasia,2012,14(3):219-227.
22
Purrington KS, Slager S, Eccles D, et al. Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer [J]. Carcinogenesis,2014,35(5):1012-1019.
23
Yuan Y, Leszczynska M, Konstantinovsky S, et al. Netrin-4 is upregulated in breast carcinoma effusions compared to corresponding solid tumors [J]. Diagn Cytopathol, 2011,39(8):562-566.
24
Fujikane T, Nishikawa N, Toyota M, et al. Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer [J]. Breast Cancer Res Treat,2010,122(3):699-710.
[1] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[2] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[3] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[4] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[5] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[6] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[7] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[8] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[9] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[10] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[11] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[12] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[13] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[14] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[15] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
阅读次数
全文


摘要